Skip to content

AHC International Media Library

Alternating Hemplegia of Childhood and ATP1A3 disorders

  • Interviews
  • Home Videos
  • News
  • Associations
  • Documentaries
  • Presentations
  • Contact
  • About AHCIM
  • Articles
  • Toggle search form

Dr. Al George – AHC interview 2019 – Reykjavik, Iceland

Posted on September 19, 2020September 19, 2020 By siggi

ATP1A3 SYMPOSIUM IN DISEASE – REYKJAVIK, ICELAND 2019

Dr. George tells us about the research Northwestern University is doing with Flunarizine a drug which is the most common in treatment for AHC
He also tells us about other methods which may be a treatment option for AHC and related diseases.


Alfred L. George, Jr., MD:

Chair, Department of Pharmacology
Director, Center for Pharmacogenomics
Magerstadt Professor of Pharmacology
Professor of Pharmacology

Interviews Tags:AHC, al georg, Alfred Georg, research, southwestern

Post navigation

Previous Post: Dr. Steven Gray – ATP1A3 symposium in Reykjavik, Iceland
Next Post: Prof. Sanjay Sisodiya explains AHC

Related Posts

AAV gene therapy for AHC – Any donation is a step forward Associations
Simon Frost at the ATP1A3 Symposium in Disease – Chicago 2018 Interviews
Dr. Kenneth Silver at the ATP1A3 symposium in Chicago 1/3 Interviews
Kenneth Silver – Why do not all AHC Patients have the ATP1A3 mutation? 2/3 Interviews
Leigh Mack at the ATP1A3 symposium in Chicago 2018 Interviews
ATP1A3 Symposium in Disease – Reykjavik 2019 Associations

Copyright © 2026 AHC International Media Library.

Powered by PressBook Masonry Dark